ClinicalTrials.gov
public full text
Public Domain
Efficacy of a New Nanoemulsion Artificial Tear Targeting Dry Eye Disease
This is a prospective cohort study to compare subjective changes in symptoms using the Ocular Surface Disease Index (OSDI) questionnaire, following the recommended dosage of the new nanoemulsion eye drops (Systane Complete)in mild to moderate dry eye patients, and to investigate objective ocular surface changes using modern clinical instruments during the study period.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Effectiveness of Iota-Carrageenan Eye Drops for the Treatment of Dry Eye Disease#18835
- Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests#891950
- Comparison of Autologous Serum Versus Preservative Free Artificial Tear#908030
- Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops#899050
- Effectiveness of Systane PRO for Mild to Moderate Dry Eye Disease#858057
Record · ID 1030025
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive